Crawford Investment Counsel’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $147M | Sell |
744,724
-24,758
| -3% | -$4.77M | 2.51% | 4 |
|
|
2025
Q4 | $141M | Sell |
769,482
-13,555
| -2% | -$2.38M | 2.36% | 4 |
|
|
2025
Q3 | $120M | Buy |
783,037
+13,607
| +2% | +$2.06M | 1.99% | 10 |
|
|
2025
Q2 | $108M | Sell |
769,430
-14,319
| -2% | -$2.01M | 1.88% | 12 |
|
|
2025
Q1 | $115M | Sell |
783,749
-23,534
| -3% | -$3.4M | 2.04% | 10 |
|
|
2024
Q4 | $106M | Buy |
807,283
+39,266
| +5% | +$5.5M | 1.9% | 12 |
|
|
2024
Q3 | $120M | Sell |
768,017
-4,935
| -0.6% | -$797K | 2.04% | 8 |
|
|
2024
Q2 | $121M | Sell |
772,952
-5,467
| -0.7% | -$823K | 2.3% | 4 |
|
|
2024
Q1 | $105M | Buy |
778,419
+23,799
| +3% | +$3.15M | 1.96% | 11 |
|
|
2023
Q4 | $102M | Sell |
754,620
-7,245
| -1% | -$942K | 2.04% | 9 |
|
|
2023
Q3 | $103M | Buy |
761,865
+8,571
| +1% | +$1.17M | 2.24% | 7 |
|
|
2023
Q2 | $108M | Sell |
753,294
-22,364
| -3% | -$3.29M | 2.19% | 8 |
|
|
2023
Q1 | $108M | Sell |
775,658
-31,929
| -4% | -$4.3M | 2.3% | 6 |
|
|
2022
Q4 | $110M | Sell |
807,587
-6,662
| -0.8% | -$835K | 2.36% | 8 |
|
|
2022
Q3 | $89.3M | Sell |
814,249
-8,324
| -1% | -$1.06M | 2.11% | 11 |
|
|
2022
Q2 | $109M | Sell |
822,573
-48,457
| -6% | -$6.36M | 2.4% | 7 |
|
|
2022
Q1 | $116M | Sell |
871,030
-22,971
| -3% | -$2.75M | 2.24% | 5 |
|
|
2021
Q4 | $104M | Buy |
894,001
+2,687
| +0.3% | +$316K | 1.98% | 11 |
|
|
2021
Q3 | $107M | Buy |
891,314
+1,967
| +0.2% | +$229K | 2.19% | 6 |
|
|
2021
Q2 | $107M | Sell |
889,347
-56,352
| -6% | -$6.18M | 2.15% | 9 |
|
|
2021
Q1 | $94M | Buy |
945,699
+39,374
| +4% | +$3.96M | 2.12% | 10 |
|
|
2020
Q4 | $90.6M | Sell |
906,325
-6,260
| -0.7% | -$663K | 2.24% | 10 |
|
|
2020
Q3 | $100M | Buy |
912,585
+3,370
| +0.4% | +$375K | 2.73% | 5 |
|
|
2020
Q2 | $96.2M | Sell |
909,215
-44,144
| -5% | -$4.56M | 2.76% | 4 |
|
|
2020
Q1 | $85.2M | Buy |
953,359
+39,248
| +4% | +$3.69M | 2.86% | 2 |
|
|
2019
Q4 | $91.2M | Buy |
914,111
+108,463
| +13% | +$10.2M | 2.36% | 4 |
|
|
2019
Q3 | $71.8M | Sell |
805,648
-5,603
| -0.7% | -$486K | 1.99% | 16 |
|
|
2019
Q2 | $67M | Sell |
811,251
-10,727
| -1% | -$841K | 1.89% | 20 |
|
|
2019
Q1 | $66.5M | Sell |
821,978
-8,000
| -1% | -$631K | 1.98% | 17 |
|
|
2018
Q4 | $63M | Sell |
829,978
-41,518
| -5% | -$3.24M | 2.14% | 15 |
|
|
2018
Q3 | $69M | Buy |
871,496
+8,262
| +1% | +$625K | 2.1% | 15 |
|
|
2018
Q2 | $60.6M | Buy |
863,234
+55,243
| +7% | +$3.97M | 1.93% | 20 |
|
|
2018
Q1 | $56.5M | Buy |
807,991
+507,060
| +168% | +$35.1M | 1.78% | 24 |
|
|
2017
Q4 | $20.9M | Buy |
300,931
+5,104
| +2% | +$344K | 0.65% | 48 |
|
|
2017
Q3 | $20M | Buy |
295,827
+79,398
| +37% | +$5.02M | 0.65% | 48 |
|
|
2017
Q2 | $14.8M | Sell |
216,429
-60,625
| -22% | -$3.96M | 0.51% | 57 |
|
|
2017
Q1 | $17.3M | Buy |
277,054
+26,572
| +11% | +$1.55M | 0.61% | 44 |
|
|
2016
Q4 | $13.7M | Buy |
250,482
+15,364
| +7% | +$872K | 0.5% | 49 |
|
|
2016
Q3 | $15.5M | Buy |
235,118
+42,195
| +22% | +$2.76M | 0.57% | 48 |
|
|
2016
Q2 | $11.6M | Buy |
192,923
+42,085
| +28% | +$2.44M | 0.46% | 49 |
|
|
2016
Q1 | $8.49M | Buy |
150,838
+145,068
| +2,514% | +$8.72M | 0.36% | 56 |
|
|
2015
Q4 | $392K | Sell |
5,770
-910
| -14% | -$59.7K | 0.02% | 199 |
|
|
2015
Q3 | $425K | Buy |
6,680
+435
| +7% | +$28.6K | 0.02% | 203 |
|
|
2015
Q2 | $398K | Sell |
6,245
-34,210
| -85% | -$2.34M | 0.02% | 202 |
|
|
2015
Q1 | $2.77M | Buy |
40,455
+625
| +2% | +$43.4K | 0.1% | 85 |
|
|
2014
Q4 | $2.8M | Sell |
39,830
-2,745
| -6% | -$197K | 0.1% | 86 |
|
|
2014
Q3 | $3.04M | Buy |
42,575
+18,900
| +80% | +$1.38M | 0.11% | 82 |
|
|
2014
Q2 | $1.76M | Sell |
23,675
-29,190
| -55% | -$2.11M | 0.06% | 91 |
|
|
2014
Q1 | $3.43M | Sell |
52,865
-119,720
| -69% | -$7.73M | 0.12% | 67 |
|
|
2013
Q4 | $10.2M | Buy |
172,585
+5,390
| +3% | +$293K | 0.38% | 39 |
|
|
2013
Q3 | $8.68M | Buy |
167,195
+5,670
| +4% | +$285K | 0.34% | 40 |
|
|
2013
Q2 | $7.64M | Buy |
+161,525
| New | +$8.22M | 0.32% | 43 |
|
Other funds holding AZN
IA
VCM
VAM
Crawford Investment Counsel's AZN Position: Q1 2026 in Review
Crawford Investment Counsel reduced its AstraZeneca (AZN) stake by 3.2% in Q1 2026, selling an estimated $4.77M and leaving 744,724 shares worth $147M. The position accounts for 2.51% of the portfolio, ranked #4.
Crawford Investment Counsel first reported a position in AZN in Q2 2013 and has held it in 52 quarters since. 1,379 funds tracked by Wall St. Rank hold AZN as of Q1 2026.
- Crawford Investment Counsel held 744,724 shares of AstraZeneca worth $147M as of Q1 2026.
- Crawford Investment Counsel sold 24,758 AstraZeneca shares in Q1 2026, an estimated $4.77M.
- AstraZeneca made up 2.51% of Crawford Investment Counsel's portfolio in Q1 2026, its #4 holding.
- Crawford Investment Counsel first reported a position in AstraZeneca in Q2 2013 and has held it in 52 quarters since.
- 1,379 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.
Based on Crawford Investment Counsel's 13F filing for Q1 2026, filed 15 May 2026.